Furthermore, USP8 176 and USP11 177 enhance TGF-β/SMAD signaling by deubiquitinating and stabilizing TβRII, increasing plasma membrane expression and promoting EMT, invasion, and metastasis in BC cells in vitro and in vivo. Here, TGFB1 is linked to breast cancer.